fig1

On the potential of group-specific component (GC) inhibition for treating metabolic disease

Figure 1. Three-dimensional structural diagram of GC protein and its domains (A). Subsequent panels highlight GC subdomains containing its vitamin D binding site (B), C5a enhancing site (C), fatty acid binding sites (D), and actin binding site (E). GC: Group-specific component; C5a: complement component 5a.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/